Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
ADC ID |
DRG0ZDRMF
|
|||||
---|---|---|---|---|---|---|
ADC Name |
h1F6-3 MMAE DAR4
|
|||||
Synonyms |
h1F6-3-MMAE
Click to Show/Hide
|
|||||
Organization |
Seagen Inc.
|
|||||
Drug Status |
Investigative
|
|||||
Indication |
In total 2 Indication(s)
B-cell lymphoma [ICD11:2A86]
Investigative
Renal cell carcinoma [ICD11:2C90]
Investigative
|
|||||
Drug-to-Antibody Ratio |
4
|
|||||
Antibody Name |
Vorsetuzumab
|
Antibody Info | ||||
Antigen Name |
CD70 antigen (CD70)
|
Antigen Info | ||||
Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
Linker Name |
Thr-Dpr-MA
|
Linker Info |
General Information of The Activity Data Related to This ADC
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | 27.00 ng/mL | Positive CD70 expression (CD70+++/++) | ||
Method Description |
Log phase cultures of cells were collected and cells plated at seeding densities ranging from 500 - 10,000 cells/well according to pre-determined conditions.After incubating 24 hours to allow surface protein reconstitution, serial dilutions of test conjugates were added and cultures incubated further for 4 days.
|
||||
In Vitro Model | Clear cell renal cell carcinoma | Caki-1 cells | CVCL_0234 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | 28.00 ng/mL | Positive CD70 expression (CD70+++/++) | ||
Method Description |
Log phase cultures of cells were collected and cells plated at seeding densities ranging from 500 - 10,000 cells/well according to pre-determined conditions.After incubating 24 hours to allow surface protein reconstitution, serial dilutions of test conjugates were added and cultures incubated further for 4 days.
|
||||
In Vitro Model | Renal cell carcinoma | 786-O cells | CVCL_1051 |
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.